Found: 18
Select item for more details and to access through your institution.
Serum level of taurine would be associated with the amelioration of minimal hepatic encephalopathy in cirrhotic patients.
- Published in:
- Hepatology Research, 2016, v. 46, n. 2, p. 215, doi. 10.1111/hepr.12565
- By:
- Publication type:
- Article
Chronic Liver Disease Questionnaire would be a primary screening tool of neuropsychiatric test detecting minimal hepatic encephalopathy of cirrhotic patients.
- Published in:
- Hepatology Research, 2015, v. 45, n. 9, p. 994, doi. 10.1111/hepr.12442
- By:
- Publication type:
- Article
mi R-214 and hypoxia down-regulate Necl-2/ CADM1 and enhance Erb B2/ Erb B3 signaling.
- Published in:
- Genes to Cells, 2013, v. 18, n. 3, p. 195, doi. 10.1111/gtc.12027
- By:
- Publication type:
- Article
Mutational diversity of NS5A and NS3 during triple therapy(telaprevir, pegylated-interferon-α 2b and ribavirin)for genotype 1b chronic hepatitis C: The Kobe Hepatitis Therapeutic Group.
- Published in:
- International Journal of Molecular Medicine, 2014, v. 33, n. 6, p. 1652, doi. 10.3892/ijmm.2014.1706
- By:
- Publication type:
- Article
Real-World Comparison of Elobixibat and Lubiprostone Treatment in Patients with Chronic Constipation: A Propensity Score-Matched Analysis.
- Published in:
- Digestive Diseases, 2021, v. 39, n. 4, p. 341, doi. 10.1159/000512745
- By:
- Publication type:
- Article
Risk Factors for Adverse Events in Patients with Chronic Constipation Following Lubiprostone Administration.
- Published in:
- Digestive Diseases, 2021, v. 39, n. 1, p. 10, doi. 10.1159/000508864
- By:
- Publication type:
- Article
Serum NX-DCP as a New Noninvasive Model to Predict Significant Liver Fibrosis in Chronic Hepatitis C.
- Published in:
- Hepatitis Monthly, 2015, v. 15, n. 2, p. 1, doi. 10.5812/hepatmon.22978
- By:
- Publication type:
- Article
Efficacy and safety of elobixibat in combination with or switched from conventional treatments of chronic constipation: A retrospective observational study.
- Published in:
- JGH Open, 2024, v. 8, n. 8, p. 1, doi. 10.1002/jgh3.70019
- By:
- Publication type:
- Article
Factors associated with the response to atezolizumab/bevacizumab combination therapy for hepatocellular carcinoma.
- Published in:
- JGH Open, 2023, v. 7, n. 7, p. 476, doi. 10.1002/jgh3.12932
- By:
- Publication type:
- Article
Significance of post‐progression therapy after tyrosine kinase inhibitors for advanced hepatocellular carcinoma.
- Published in:
- JGH Open, 2022, v. 6, n. 6, p. 427, doi. 10.1002/jgh3.12772
- By:
- Publication type:
- Article
Feasibility of the lidocaine injection method during esophageal endoscopic submucosal dissection.
- Published in:
- JGH Open, 2020, v. 4, n. 2, p. 251, doi. 10.1002/jgh3.12257
- By:
- Publication type:
- Article
Downregulation of CXCR4 in Metastasized Breast Cancer Cells and Implication in Their Dormancy.
- Published in:
- PLoS ONE, 2015, v. 10, n. 6, p. 1, doi. 10.1371/journal.pone.0130032
- By:
- Publication type:
- Article
Reduction in Non-Protein Respiratory Quotient Is Related to Overall Survival after Hepatocellular Carcinoma Treatment.
- Published in:
- PLoS ONE, 2013, v. 8, n. 3, p. 1, doi. 10.1371/journal.pone.0055441
- By:
- Publication type:
- Article
Portal venous tumor growth-type of hepatocellular carcinoma without liver parenchyma tumor nodules: a case report.
- Published in:
- 2013
- By:
- Publication type:
- Case Study
Endoscopic submucosal dissection for early gastric cancer on the lesser curvature in upper third of the stomach is a risk factor for postoperative delayed gastric emptying.
- Published in:
- 2018
- By:
- Publication type:
- journal article
The Effects of Switching to Vonoprazan, a Novel Potassium-Competitive Acid Blocker, on Gastric Acidity and Reflux Patterns in Patients with Erosive Esophagitis Refractory to Proton Pump Inhibitors.
- Published in:
- Digestion, 2017, v. 96, n. 1, p. 52, doi. 10.1159/000478255
- By:
- Publication type:
- Article
A Comparative Study of a New Class of Gastric Acid Suppressant Agent Named Vonoparazan versus Esomeprazole for the Eradication of Helicobacter pylori.
- Published in:
- Digestion, 2016, v. 94, n. 4, p. 240, doi. 10.1159/000454762
- By:
- Publication type:
- Article
Propensity score matching analysis: incidence and risk factors for "stardust" gastric mucosa, a novel gastric finding potentially induced by vonoprazan.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 53, n. 1, p. 94, doi. 10.1111/apt.16151
- By:
- Publication type:
- Article